Antiphospholipid Syndrome (Record no. 101318)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 03982nam a22004695i 4500 |
| 001 - CONTROL NUMBER | |
| control field | 978-1-4614-3194-7 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | DE-He213 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20140220083246.0 |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
| fixed length control field | cr nn 008mamaa |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 120519s2012 xxu| s |||| 0|eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9781461431947 |
| -- | 978-1-4614-3194-7 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1007/978-1-4614-3194-7 |
| Source of number or code | doi |
| 050 #4 - LIBRARY OF CONGRESS CALL NUMBER | |
| Classification number | RC927-927.5 |
| 072 #7 - SUBJECT CATEGORY CODE | |
| Subject category code | MJM |
| Source | bicssc |
| 072 #7 - SUBJECT CATEGORY CODE | |
| Subject category code | MED083000 |
| Source | bisacsh |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER | |
| Classification number | 616.723 |
| Edition number | 23 |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Erkan, Doruk. |
| Relator term | editor. |
| 245 10 - TITLE STATEMENT | |
| Title | Antiphospholipid Syndrome |
| Medium | [electronic resource] : |
| Remainder of title | Insights and Highlights from the 13th International Congress on Antiphospholipid Antibodies / |
| Statement of responsibility, etc | edited by Doruk Erkan, Silvia S. Pierangeli. |
| 264 #1 - | |
| -- | Boston, MA : |
| -- | Springer US : |
| -- | Imprint: Springer, |
| -- | 2012. |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | XVII, 312 p. 28 illus., 20 illus. in color. |
| Other physical details | online resource. |
| 336 ## - | |
| -- | text |
| -- | txt |
| -- | rdacontent |
| 337 ## - | |
| -- | computer |
| -- | c |
| -- | rdamedia |
| 338 ## - | |
| -- | online resource |
| -- | cr |
| -- | rdacarrier |
| 347 ## - | |
| -- | text file |
| -- | |
| -- | rda |
| 505 0# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Overview of the Last 25 years and 13 International Congresses on Antiphospholipid Antibodies -- What is the Origin of Antiphospholipid Antibodies? -- What is the Genetics of Antiphospholipid Antibodies/Syndrome? -- What is the Mechanism(s) of Antiphospholipid Antibody-mediated Thrombosis? -- What is the Mechanism(s) of Antiphospholipid Antibody-mediated Pregnancy Morbidity? -- What are the Target Cells and Receptors Recognized by Antiphospholipid Antibodies? -- Task Force Report on “Criteria” Antiphospholipid Antibody Tests -- Task Force Report on “Non-Criteria” Antiphospholipid Antibody Tests -- Task Force Report on Obstetric Antiphospholipid Syndrome -- Task Force Report on Brain Involvement in Antiphospholipid Syndrome -- Task Force Report on the Management of Thrombosis in Antiphospholipid Syndrome -- Task Force Report on Catastrophic Antiphospholipid Syndrome -- Task Force Report on Non-criteria aPL Manifestations: Thrombocytopenia -- Task Force Report on Non-criteria Manifestations: Nephropathy -- Task Force Report on Non-criteria Manifestations: Cardiac Valve Disease -- Task Force Report on Non-criteria Manifestations: Skin -- Task Force Report on Antiphospholipid Syndrome Clinical Research -- What are the Potential Future Treatments in Antiphospholipid Syndrome? -- Remembrance of Predictions of Past -- What Should Patients Know about Antiphospholipid Antibodies and Antiphospholipid Syndrome?. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc | The International Congress on Antiphospholipid Antibodies is held every three years to discuss the recent advances and future directions in Antiphospholipid Syndrome (APS). This volume collects the scientific highlights and new findings about APS that were generated from the most recent 13th Congress, held in Galveston, Texas in 2010. Chapters were written by an internationally-distinguished group of scientists from the point-of-view of multiple specialty areas. Each chapter was written in a uniform and systematic basis to present the latest evidence-based research, including the basic science of APS, task force reports from the Congress on controversial aspects of APS, and future directions of APS research. This book will appeal to all clinicians involved in the treatment and management of APS patients, to residents in a variety of medical subspecialties, and to research scientists interested in a better understanding of this complex and evolving disease. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Medicine. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Allergy. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Internal medicine. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Rheumatology. |
| 650 14 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Medicine & Public Health. |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Rheumatology. |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Internal Medicine. |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Allergology. |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Pierangeli, Silvia S. |
| Relator term | editor. |
| 710 2# - ADDED ENTRY--CORPORATE NAME | |
| Corporate name or jurisdiction name as entry element | SpringerLink (Online service) |
| 773 0# - HOST ITEM ENTRY | |
| Title | Springer eBooks |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY | |
| Display text | Printed edition: |
| International Standard Book Number | 9781461431930 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | http://dx.doi.org/10.1007/978-1-4614-3194-7 |
| 912 ## - | |
| -- | ZDB-2-SME |
No items available.